ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 745287 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 745287; 2) Community: the network communities that were significantly associated with the response to NSC 745287; 3) Molecule: the relationships between components within communities and NSC 745287; 4) MDR: the compounds that were significantly associated with the NSC 745287.

NSC Compound Enrichment Correlation
NSC 736739 E2GG, 5,7-bis[(4-methoxybenzyl)amino]-3-isopropylpyrazolo[4,3-d]py rimidine 0.0459335986102865 -0.21660795
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0459335986102865 -0.0080046195
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0459335986102865 -0.21492975
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0459335986102865 -0.26379982
NSC 763564 EMD-534085 0.0459335986102865 -0.12807245
NSC 755443 Null 0.0462077035966084 -0.077243036
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0462077035966084 -0.13175005
NSC 106969 CENTAUREIDIN 0.0462077035966088 -0.19828683
NSC 107124 Camptothecin Derivative 0.0462077035966088 0.12471144
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0462077035966088 -0.10939151
Total:69  Current:61    [First] [Prev] [Next] [Last]